Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 2501 - 500 out of 500 displayed.
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Reset ↻

Nuvalent Presents New Preclinical Data Supporting Profiles of HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor, Zidesamtinib, at AACR Annual Meeting 2024

Read more ››

By: PR Newswire Association LLC. - 08 Apr 2024

Related companies: Nuvalent, Inc.

Phanes Therapeutics' PT217 granted Fast Track Designation by the FDA

Read more ››

By: PR Newswire Association LLC. - 08 Apr 2024

Related companies: Phanes Therapeutics, Inc.

Oral report | The positive interim analysis results from the Phase III clinical study of Akeso's Cadonilimab (PD-1/CTLA-4 BsAb) plus chemotherapy as first-line treatment for advanced gastric cancer presented at 2024 AACR

Read more ››

By: PR Newswire Association LLC. - 08 Apr 2024

Related companies: Akeso Biomedical, Inc. | Akeso Ventures Inc

GV20 Therapeutics Presents Preclinical Data on GV20-0251 for Solid Tumors Targeting IGSF8 at AACR Annual Meeting 2024

Read more ››

By: PR Newswire Association LLC. - 08 Apr 2024

Related companies: GV20 Therapeutics

Accent Therapeutics Presents Data Supporting Two Lead Programs at AACR 2024 Annual Meeting

Read more ››

By: PR Newswire Association LLC. - 08 Apr 2024

Related companies: Accent Therapeutics, Inc

Giant-Cell Arteritis Market to Showcase Positive Growth at a CAGR of 9.3% by 2034 | DelveInsight

Read more ››

By: PR Newswire Association LLC. - 08 Apr 2024

HPV16+ Cancer Treatment Market is Expected to Showcase Significant Growth by 2034, Assesses DelveInsight | Key Companies in the Market - Nykode Therapeutics, Roche, ISA Pharmaceuticals, Regeneron, Transgene

Read more ››

By: PR Newswire Association LLC. - 08 Apr 2024

Positive Results from Phase 3 OPTIMIZE-1 Trial of Once Daily OCS-01 for the Treatment of Inflammation and Pain Following Cataract Surgery Presented at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: Oculis Holding AG

Inozyme Pharma Announces Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency (PXE) and ENPP1 Deficiency

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: Inozyme Pharma

Ocugen, Inc. Announces U.S. FDA Clearance of IND Amendment to Initiate OCU400 Phase 3 Clinical Trial — First Gene Therapy to Enter Phase 3 with a Broad Retinitis Pigmentosa Indication

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: Ocugen, Inc.

XORTX Announces Participation in Spring 2024 Investor Conferences

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: XORTX Therapeutics Inc

Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: Pluri Inc.

Gritstone bio Presents Improvements to EDGE™ Platform at AACR 2024

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: Gritstone bio

Eyenovia Announces Updated Strategy and Corporate Priorities to Focus on Shareholder Value Generation and Immediate Commercial Opportunities

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: Eyenovia, Inc.

TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: TELA Bio, Inc

Kymera Therapeutics Announces Scientific Presentations at the American Association for Cancer Research 2024 Annual Meeting

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: Kymera Therapeutics Inc.

NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: NextCure, Inc

Principal Investigator from City of Hope National Medical Center Invited to Present Clinical Data from Marker Therapeutics APOLLO Study at 11th Global Summit on Hematologic Malignancies

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: Marker Therapeutics, Inc.

Kraig Biocraft Laboratories Signs Landmark Agreement in Vietnam's Silk Production Capital

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: Kraig Biocraft Laboratories, Inc.

World Orphan Drug Alliance Expands to Japan & South Korea and the African Subcontinent

Read more ››

By: GlobeNewswire - 08 Apr 2024

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

to the top ↑